Source: Annual Congress 2001 - Inflammation, infection and exercise capacity in cystic fibrosis patients
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. V. Shmarina, A. L. Pukhalsky, L. A. Shabalova, S. N. Kokarovtseva, M. S. Blakher (Moscow, Russia). Cystic fibrosis patients were incapable of excessive IL-10 production in response to antigen challenge. Eur Respir J 2001; 16: Suppl. 31, 854

Member's Comments

No comment yet.

Related content which might interest you: Cystic fibrosis patients with ΔF508 mutation demonstrate local immune response of Th2 type Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis Source: Eur Respir J 2012; 39: 297-304 Year: 2012 The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease Source: Eur Respir J 2011; 37: 1378-1385 Year: 2011 Circulating inflammatory cytokines in adult cystic fibrosis patients Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019 Year: 2021 Exaggerated IL-6 responses to LPS after viral airway infection in mice is mediated by endogenous TNF-a production Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens Year: 2007 Potentiated airway inflammation and attenuated subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001 Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity Source: ERJ Open Res, 4 (2) 00068-2017; 10.1183/23120541.00068-2017 Year: 2018 Oral presentation: Macrophages are required to maintain type-2 dependent inflammation, immunity and fibrosis Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001 Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Source: Eur Respir J 2009; 34: 655 Year: 2009 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Ivacaftor decreases monocyte sensitivity to interferon-? in people with cystic fibrosis Source: ERJ Open Res, 6 (2) 00318-2019; 10.1183/23120541.00318-2019 Year: 2020 Bronchial epithelial cells from COPD patients overproduce an upstream Th2 regulator cytokine in response to viral stimuli Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009 Cytokine production in whole blood and disease severity in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Increased priming of blood neutrophils in children with clinically stable cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002 Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 719s Year: 2004